PERLINI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 8.912
AS - Asia 6.654
EU - Europa 5.371
SA - Sud America 852
AF - Africa 259
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.081
Nazione #
US - Stati Uniti d'America 8.706
CN - Cina 2.899
SG - Singapore 1.586
IE - Irlanda 1.175
HK - Hong Kong 764
RU - Federazione Russa 686
VN - Vietnam 634
BR - Brasile 631
DE - Germania 608
IT - Italia 589
UA - Ucraina 586
FI - Finlandia 540
FR - Francia 336
GB - Regno Unito 273
SE - Svezia 240
IN - India 173
ZA - Sudafrica 163
CA - Canada 111
AR - Argentina 80
JP - Giappone 72
IQ - Iraq 69
BD - Bangladesh 67
TR - Turchia 65
MX - Messico 64
BE - Belgio 56
PL - Polonia 53
ES - Italia 41
ID - Indonesia 40
NL - Olanda 39
EC - Ecuador 35
PK - Pakistan 35
CO - Colombia 29
UZ - Uzbekistan 28
AT - Austria 27
CZ - Repubblica Ceca 27
IR - Iran 27
VE - Venezuela 23
CL - Cile 22
LT - Lituania 21
PH - Filippine 21
AU - Australia 19
JO - Giordania 19
MA - Marocco 19
MY - Malesia 18
SA - Arabia Saudita 18
PY - Paraguay 16
EG - Egitto 14
AL - Albania 13
DZ - Algeria 13
LB - Libano 12
AZ - Azerbaigian 11
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 9
IL - Israele 9
KE - Kenya 8
JM - Giamaica 7
SN - Senegal 7
UY - Uruguay 7
AM - Armenia 6
BH - Bahrain 6
GR - Grecia 6
KG - Kirghizistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
CH - Svizzera 5
ET - Etiopia 5
GT - Guatemala 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GE - Georgia 4
AO - Angola 3
CG - Congo 3
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
EU - Europa 3
KW - Kuwait 3
LK - Sri Lanka 3
MU - Mauritius 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
HN - Honduras 2
Totale 22.040
Città #
Chandler 1.233
Dublin 1.173
Singapore 855
San Jose 822
Ashburn 747
Dallas 738
Hong Kong 737
Jacksonville 733
Nanjing 559
Beijing 557
Boardman 351
Ann Arbor 243
Los Angeles 239
Lauterbourg 231
Princeton 220
Nanchang 218
Lawrence 210
Wilmington 210
Ho Chi Minh City 209
Helsinki 183
Shenyang 164
Hebei 160
Munich 153
New York 151
Medford 146
Hanoi 145
Milan 144
Changsha 138
Moscow 137
Johannesburg 136
Jiaxing 111
Redondo Beach 111
Pavia 100
Buffalo 99
Shanghai 95
Tianjin 84
Hangzhou 76
São Paulo 68
Tokyo 66
Turku 66
Orem 59
Brussels 56
Woodbridge 51
Santa Clara 47
Council Bluffs 43
Toronto 43
Warsaw 42
Norwalk 41
Seattle 39
Da Nang 38
Frankfurt am Main 38
Brooklyn 36
Chennai 36
Falls Church 36
Montreal 36
Chicago 35
London 35
Falkenstein 34
Saint Petersburg 34
Houston 33
Haiphong 32
Nuremberg 31
Verona 31
Boston 30
Guangzhou 30
Fairfield 29
The Dalles 29
Atlanta 28
Denver 27
Mexico City 25
Baghdad 24
Stockholm 24
Amsterdam 23
Brno 23
Phoenix 23
Tashkent 23
Rio de Janeiro 22
San Francisco 22
Zhengzhou 22
Manchester 20
Des Moines 18
Piscataway 18
Columbus 17
Amman 16
Curitiba 16
Jinan 16
Poplar 16
Pune 16
Taizhou 16
Mumbai 15
Vienna 15
Ankara 14
Biên Hòa 14
Guayaquil 14
Washington 14
Charlotte 13
Istanbul 13
Kunming 13
Rome 13
Dhaka 12
Totale 14.447
Nome #
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance 169
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 158
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 156
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 152
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 148
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 147
La simulazione su manichino migliora l’abilità degli studenti di Medicina nell’auscultazione cardiaca? L’esperienza di Pavia 146
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 146
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 145
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 145
Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. 142
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 140
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 138
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 136
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 134
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 133
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 132
Treatment of chronic heart failure: an expert system advisor for general practitioners. 131
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 131
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 130
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 129
Adenosine 128
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 127
A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis 124
Adherence of the guidelines in an Italian ED in case of minor head trauma (MHI) in real life 124
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 124
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 124
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 123
Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? 122
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 122
Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. 120
Experience from controlled trials of physical-training in chronic heart-failure-protocol and patient factors in effectiveness in the improvement in exercise tolerance 119
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 119
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 119
Right ventricular function in AL amyloidosis: characteristics and prognostic implication 116
Comparative analysis of a 4-lead portable smartphone based electrocardiograph versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 116
Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening 115
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System 115
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 115
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 114
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 113
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 113
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 112
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 111
Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. 110
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 110
Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19 110
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 109
Analisi preliminare di un sistema esperto per la diagnosi cardiologica incruenta. 107
Simulation-guided cardiac auscultation improves medical students' clinical skills: the Pavia pilot experience 107
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 106
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 106
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 106
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 106
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 105
Assessment of regional myocardial performance with end-systolic pressure lenght and thickness relationships. 105
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 105
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 104
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 104
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 104
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 104
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 103
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 103
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44 102
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis 102
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 102
Machine-Learning-Based COVID-19 and Dyspnoea Prediction Systems for the Emergency Department 101
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis 101
Lack of contribution of autonomic influences to vascular nitric oxide release? Studies in the unanesthetized rat. 101
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. 101
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis 101
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 101
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 100
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 100
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 99
Evaluation of matrix metalloproteases activity in Guinea pig cardiac hypertrophy. 99
An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis 99
QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine 99
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 98
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 97
Semplice algoritmo per la valutazione del rilasciamento isovolumetrico del ventricolo sinistro. 96
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 96
Deep learning and lung ultrasound for Covid-19 pneumonia detection and severity classification 96
Antiadrenergic effects of adenosine in pressure overload hypertrophy. 95
Ultrasonic integrated backscatter as a useful and tool to noninvasively study myocardial function and fibrosis in hypertensive heart disease 95
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 94
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 94
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 94
Enhanced vascular reactivity in the sympathectomized rat: studies in vivo and in small isolated resistance arteries 93
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 93
Reproducibility of ultrasound assessment of common carotic and femoral artery compliance and distensibility in the anesthetized rat. 92
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 92
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 92
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 91
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy 91
Hypertensive heart disease: diagnostic and therapeutic guidelines.Commissione congiunta Società Italiana dell'lpertensione Arteriosa; Società Italiana di Cardiologia; Associazione Nazionale Medici Cardiologi Ospedalieri. 91
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 91
Le alterazioni della dinamica del riempimento ventricolare sinistro predicono la progressione dell'ipertrofia ventricolare sinistra verso l'insufficienza cardiaca. 90
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 90
Early development of metabolic syndrome in patients subjected to lung transplantation 90
Totale 11.296
Categoria #
all - tutte 91.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 0 0 0 0 175 144 30
2021/20221.017 19 15 38 16 39 36 31 71 61 31 153 507
2022/20233.398 379 240 51 296 350 350 3 184 1.392 17 90 46
2023/20241.268 164 201 47 86 116 292 38 75 10 60 83 96
2024/20253.836 129 278 74 162 93 220 219 233 928 142 437 921
2025/20268.140 643 621 924 975 1.066 422 1.705 397 816 571 0 0
Totale 22.387